Clinical trial
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects…
NCT00424190 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00424190 |
|---|---|
| Title | Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections |
| Official title | A Phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin and Skin Structure Infection |
| Acronym | cSSSI |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacterial Infections |
| Intervention type | Drug |
| Interventions | IV Vancomycin plus IV Aztreonam, Ceftaroline |
| Enrollment | 698 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Jan 18, 2007 |
| Last update posted | Mar 14, 2017 |
| Countries | Argentina, Brazil, Chile, Germany, Mexico, Peru, Poland, Romania, Russia, Ukraine, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: